Skip to main content

Animations

MJFF Publications

231 - 240 of 9034 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2020
  • 2021
  • 2021
  • 2022
  • 2022
  • 2021
  • 2020
  • 2022
  • Summary Details
    RESTRICTED
    Title: Symptomatic Care in Multiple System Atrophy: State of the Art
    Journal Name: The Cerebellum
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12311-022-01411-6
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Digital Technology in Movement Disorders: Updates, Applications, and Challenges
    Journal Name: Current Neurology and Neuroscience Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11910-021-01101-6
    Citation Count: 30
  • Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease
    2020
    Summary Details
    RESTRICTED
    Title: Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40263-020-00727-3
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40263-020-00782-w
    Citation Count: 17
  • Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders
    2021
    Summary Details
    RESTRICTED
    Title: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40263-021-00796-y
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40263-022-00963-9
    Citation Count: 14
  • Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
    2022
    Summary Details
    RESTRICTED
    Title: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
    Journal Name: CNS Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability
    Journal Name: Drugs & Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40266-021-00853-7
    Citation Count: 6
  • Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid
    2020
    Summary Details
    RESTRICTED
    Title: Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.arr.2020.101130
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.arr.2022.101648
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.